Tekla Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $2.37M | Hold |
|
|||||
|
2023
Q1 | $2.43M | Hold |
|
|||||
|
2022
Q4 | $2.97M | Sell |
|
|||||
|
2022
Q3 | $8.55M | Buy |
|
|||||
|
2022
Q2 | $5.62M | Hold |
|
|||||
|
2022
Q1 | $6.89M | Hold |
|
|||||
|
2021
Q4 | $12.3M | Hold |
|
|||||
|
2021
Q3 | $14.8M | Hold |
|
|||||
|
2021
Q2 | $13.5M | Hold |
|
|||||
|
2021
Q1 | $14.4M | Hold |
|
|||||
|
2020
Q4 | $18.4M | Buy |
|
|||||
|
2020
Q3 | $13.1M | Hold |
|
|||||
|
2020
Q2 | $8.99M | Hold |
|
|||||
|
2020
Q1 | $6.06M | Buy |
|
|||||
|
2019
Q4 | $9.13M | Sell |
|
|||||
|
2019
Q3 | $6.21M | Buy |
|
|||||
|
2019
Q2 | $1.4M | Hold |
|
|||||
|
2019
Q1 | $996K | Hold |
|
|||||
|
2018
Q4 | $576K | Hold |
|
|||||
|
2018
Q3 | $640K | Buy |
|